Comparison the results of combination platinium based neoadjuvant chemotherapy regimens using gemcitabin/ciplatin with carboplatin/paclitaxel in advanced stage ovarian cancer patients; A RCT
Not Applicable
Completed
- Conditions
- Patients with advanced serous ovarian cancer, Figo stage III and IV.Malignant neoplasm of ovary
- Registration Number
- IRCT201203225283N3
- Lead Sponsor
- Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 206
Inclusion Criteria
Patients with advanced serous ovarian cancer Figo Stage III and IV; the volume of ascites, that is determined by ultrasound or CT scan, more than 500cc
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CA-125 levels. Timepoint: before surgery. Method of measurement: Lab measurement.;The volume of residual tumor. Timepoint: During surgery. Method of measurement: Clinical judgment.;The volume of ascites. Timepoint: During surgery. Method of measurement: Clinical estimation.;Bleeding. Timepoint: During surgery. Method of measurement: Clinical estimation.;Surgery duration. Timepoint: During surgery. Method of measurement: During surgery.;Death during surgery. Timepoint: During surgery. Method of measurement: observation.
- Secondary Outcome Measures
Name Time Method Wound infection, dehicsence, nausea, vomiting,diarrhea, illeus, intestinal obstruction, hospital stay. Timepoint: 24 h after surgery. Method of measurement: observation, ultrasonography, CT-scan.;Ascites collection. Timepoint: 24 hours after surgery. Method of measurement: observation, ultrasonography, CT-scan.